Sanofi Contingent Value Rights
GCVRZ
GCVRZ was delisted on the 3rd of March, 2020.
114 hedge funds and large institutions have $12.6M invested in Sanofi Contingent Value Rights in 2015 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 19 increasing their positions, 22 reducing their positions, and 16 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
3% less funds holding
Funds holding: 117 → 114 (-3)
13% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 16
14% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 22
34% less capital invested
Capital invested by funds: $19.2M → $12.6M (-$6.57M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonehill Capital Management
New York
|
+$1.97M |
| 2 |
NGA
New Generation Advisors
Manchester,
Massachusetts
|
+$861K |
| 3 |
TL
TowerView LLC
New York
|
+$99.1K |
| 4 |
EM
Elliott Management
New York
|
+$93.7K |
| 5 |
Millennium Management
New York
|
+$70.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Whitebox Advisors
Minneapolis,
Minnesota
|
-$714K |
| 2 |
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Harrisburg,
Pennsylvania
|
-$604K |
| 3 |
Brown Advisory
Baltimore,
Maryland
|
-$271K |
| 4 |
DAM
Deltec Asset Management
New York
|
-$138K |
| 5 |
CL
CSS LLC
Chicago,
Illinois
|
-$90.5K |
GCVRZ Hedge Fund Activity: Q4 2015 in Review
114 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q4 2015, worth a combined $12.6M — down 34% from $19.2M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of GCVRZ and 14 opened new positions — a net loss of 2 holders — while 22 trimmed existing stakes and 19 added.
The largest buyer was Stonehill Capital Management, adding an estimated $1.97M. The largest seller was Whitebox Advisors, cutting an estimated $714K.
- 114 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q4 2015, down from 117 in Q3 2015.
- Funds reported $12.6M of Sanofi Contingent Value Rights stock for Q4 2015, down 34% quarter-over-quarter.
- 14 funds opened new Sanofi Contingent Value Rights positions in Q4 2015 and 16 closed out, a net change of -2 holders.
- The largest Sanofi Contingent Value Rights buyer in Q4 2015 was Stonehill Capital Management, an estimated $1.97M added.
- The largest Sanofi Contingent Value Rights seller in Q4 2015 was Whitebox Advisors, an estimated $714K sold.
Based on aggregated 13F filings for Q4 2015.